Fact CheckerSign in

NCT06202196Recruiting

Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy

Evaluate the Impact of a Specific Risk Prevention Program Associated With a Therapeutic Patient Education Program on the Risk Behaviors of Adult Patients With Uncontrolled Epilepsy.

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE). 37 subjects per group will be included in this study.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
74 (estimated)
First submitted
29 Dec 2023
Start date
16 Apr 2024
Primary completion date
16 Apr 2028
Lead sponsor
University Hospital, Montpellier
Diseases
Epilepsy
NCT number
NCT06202196

What you commit to

  • Study type: Interventional
  • Planned participants: 74
  • From 16 Apr 2024 to the primary completion date, 16 Apr 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Epileptic patient who has already benefited from a TPE epilepsy program
  • Patients with major cognitive impairment
  • Failure to obtain written informed consent after a reflection period

Other

  • Patient under guardianship or legal protection (safeguard of justice)
  • Pregnant or breast-feeding women
  • Patient who for geographical, social or psychological reasons could not participate in the research
  • Any situation that, in the opinion of the investigator, could present risks to the patient and to the research
  • Participation in another therapeutic research
  • Subjects not covered by public health insurance

Who the study is looking for

  • Patient between 18 and 60 years old
  • Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator..
  • Patient agreeing to participate in a therapeutic education program (TPE)

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Gui de Chauliac
Coordinator of this site? Confirm its status
MontpellierFranceRecruiting
CHU de Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.